Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the i

Abstract:

:Anacardic acid (6-pentadecylsalicylic acid) is derived from traditional medicinal plants, such as cashew nuts, and has been linked to anticancer, anti-inflammatory, and radiosensitization activities through a mechanism that is not yet fully understood. Because of the role of nuclear factor-kappaB (NF-kappaB) activation in these cellular responses, we postulated that anacardic acid might interfere with this pathway. We found that this salicylic acid potentiated the apoptosis induced by cytokine and chemotherapeutic agents, which correlated with the down-regulation of various gene products that mediate proliferation (cyclin D1 and cyclooxygenase-2), survival (Bcl-2, Bcl-xL, cFLIP, cIAP-1, and survivin), invasion (matrix metalloproteinase-9 and intercellular adhesion molecule-1), and angiogenesis (vascular endothelial growth factor), all known to be regulated by the NF-kappaB. We found that anacardic acid inhibited both inducible and constitutive NF-kappaB activation; suppressed the activation of IkappaBalpha kinase that led to abrogation of phosphorylation and degradation of IkappaBalpha; inhibited acetylation and nuclear translocation of p65; and suppressed NF-kappaB-dependent reporter gene expression. Down-regulation of the p300 histone acetyltransferase gene by RNA interference abrogated the effect of anacardic acid on NF-kappaB suppression, suggesting the critical role of this enzyme. Overall, our results demonstrate a novel role for anacardic acid in potentially preventing or treating cancer through modulation of NF-kappaB signaling pathway.

journal_name

Blood

journal_title

Blood

authors

Sung B,Pandey MK,Ahn KS,Yi T,Chaturvedi MM,Liu M,Aggarwal BB

doi

10.1182/blood-2007-10-117994

subject

Has Abstract

pub_date

2008-05-15 00:00:00

pages

4880-91

issue

10

eissn

0006-4971

issn

1528-0020

pii

blood-2007-10-117994

journal_volume

111

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets.

    abstract::Human platelets are aggregated and induced to release their granule contents and form thromboxane by peptides as short as 6-amino acid residues (SFLLRN) corresponding to the newly released N-terminus of the thrombin receptor that is cleaved by thrombin. Using washed platelets, we found that these responses to SFLLRN (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kinlough-Rathbone RL,Rand ML,Packham MA

    更新日期:1993-07-01 00:00:00

  • Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.

    abstract::Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is widely used in healthy donors for collection of peripheral blood progenitor cells (PBPCs) for allogeneic transplantation and granulocytes for transfusion. The spectrum of its biologic and molecular activities in healthy individuals is coming into sha...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2007-07-097543

    authors: Anderlini P,Champlin RE

    更新日期:2008-02-15 00:00:00

  • Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.

    abstract::Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined by transcriptional classifications, specific signaling and survival pathways, and multiple low-frequency genetic alterations. Preclinical model systems that capture the genetic and functional heterogeneity of DLBCL are urgently needed. Here, we g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672352

    authors: Chapuy B,Cheng H,Watahiki A,Ducar MD,Tan Y,Chen L,Roemer MG,Ouyang J,Christie AL,Zhang L,Gusenleitner D,Abo RP,Farinha P,von Bonin F,Thorner AR,Sun HH,Gascoyne RD,Pinkus GS,van Hummelen P,Wulf GG,Aster JC,Weinst

    更新日期:2016-05-05 00:00:00

  • Molecular defects in hemophilia A: identification and characterization of mutations in the factor VIII gene and family analysis.

    abstract::Hemophilia A is an X-linked bleeding disorder caused by a deficiency or abnormality of factor VIII, affecting approximately 1 male in 10,000. A subgroup of the patients develops inhibitors against factor VIII during substitution therapy. Because a considerable percentage of all cases is thought to result from de novo ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Higuchi M,Kochhan L,Schwaab R,Egli H,Brackmann HH,Horst J,Olek K

    更新日期:1989-08-15 00:00:00

  • High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

    abstract::The purpose of this study was to estimate the incidence and to establish which factors were associated with an increased risk of hemorrhagic complications in an historic cohort of 117 consecutive and unselected patients with chronic idiopathic thrombocytopenic purpura (ITP). Sixty-eight patients (58%) underwent medica...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cortelazzo S,Finazzi G,Buelli M,Molteni A,Viero P,Barbui T

    更新日期:1991-01-01 00:00:00

  • Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.

    abstract::The importance of glutamine (Gln) metabolism in multiple myeloma (MM) cells and its potential role as a therapeutic target are still unknown, although it has been reported that human myeloma cell lines (HMCLs) are highly sensitive to Gln depletion. In this study, we found that both HMCLs and primary bone marrow (BM) C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-690743

    authors: Bolzoni M,Chiu M,Accardi F,Vescovini R,Airoldi I,Storti P,Todoerti K,Agnelli L,Missale G,Andreoli R,Bianchi MG,Allegri M,Barilli A,Nicolini F,Cavalli A,Costa F,Marchica V,Toscani D,Mancini C,Martella E,Dall'Asta V

    更新日期:2016-08-04 00:00:00

  • Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.

    abstract::Low concentrations of As(2)O(3) (

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jing Y,Dai J,Chalmers-Redman RM,Tatton WG,Waxman S

    更新日期:1999-09-15 00:00:00

  • CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway.

    abstract::Homing of blood-borne lymphocytes to peripheral lymph nodes (PLNs) is a multistep process dependent on the sequential engagement of L-selectin, which mediates lymphocyte rolling along the luminal surface of high endothelial venules (HEVs), followed by activation of lymphocyte integrins and transmigration through HEVs....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0841

    authors: Stein JV,Soriano SF,M'rini C,Nombela-Arrieta C,de Buitrago GG,Rodríguez-Frade JM,Mellado M,Girard JP,Martínez-A C

    更新日期:2003-01-01 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

    abstract::Granulocytic colonies grown in culture from marrow and peripheral blood from five patients with Ph1-positive CML and heterozygous at the G-6-PD locus were analyzed for G-6-PD in order to identify CFU-C that do not arise from the CML clone. The patients had both B and A enzymes in normal tissues, but their CML clones t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Singer JW,Fialkow PJ,Steinmann L,Najfeld V,Stein SJ,Robinson WA

    更新日期:1979-02-01 00:00:00

  • Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

    abstract::Daratumumab, a monoclonal CD38 antibody, is approved in the treatment of myeloma, but its efficacy and safety in light-chain (AL) amyloidosis has not been formally studied. This prospective phase 2 trial of daratumumab monotherapy for the treatment of AL amyloidosis was designed to determine the safety, tolerability, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004436

    authors: Sanchorawala V,Sarosiek S,Schulman A,Mistark M,Migre ME,Cruz R,Sloan JM,Brauneis D,Shelton AC

    更新日期:2020-04-30 00:00:00

  • Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation.

    abstract::Tissue factor (TF) is expressed on nonvascular cells and cells within the vessel wall and circulates in blood associated with microparticles. Although blood-borne TF accumulates into the developing thrombus during thrombus formation, the contribution of blood-borne TF and vessel wall TF to thrombin generation in vivo ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0935

    authors: Chou J,Mackman N,Merrill-Skoloff G,Pedersen B,Furie BC,Furie B

    更新日期:2004-11-15 00:00:00

  • Viral, immunologic, and clinical features of primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is an aggressive HIV-associated lymphoma with a relatively poor prognosis in the era of effective HIV therapy. Kaposi sarcoma herpesvirus (KSHV) is the etiologic agent, and ∼80% of tumors are coinfected with Epstein-Barr virus (EBV). A better understanding of how KSHV-related immune dys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2019-01-893339

    authors: Lurain K,Polizzotto MN,Aleman K,Bhutani M,Wyvill KM,Gonçalves PH,Ramaswami R,Marshall VA,Miley W,Steinberg SM,Little RF,Wilson W,Filie AC,Pittaluga S,Jaffe ES,Whitby D,Yarchoan R,Uldrick TS

    更新日期:2019-04-18 00:00:00

  • Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

    abstract::Chronic graft-versus-host disease (cGVHD) is a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Having shown that germinal center (GC) formation and immunoglobulin deposition are required for multiorgan system cGVHD and associated bronchiolitis obliterans syndrome (BOS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-562231

    authors: Flynn R,Du J,Veenstra RG,Reichenbach DK,Panoskaltsis-Mortari A,Taylor PA,Freeman GJ,Serody JS,Murphy WJ,Munn DH,Sarantopoulos S,Luznik L,Maillard I,Koreth J,Cutler C,Soiffer RJ,Antin JH,Ritz J,Dubovsky JA,Byrd JC,

    更新日期:2014-06-19 00:00:00

  • Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.

    abstract::Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of bleeding and infection. T cells are central to GVHD pathogenesis, and our previous studies in a chronic G...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005770

    authors: Assmann JC,Farthing DE,Saito K,Maglakelidze N,Oliver B,Warrick KA,Sourbier C,Ricketts CJ,Meyer TJ,Pavletic SZ,Linehan WM,Krishna MC,Gress RE,Buxbaum NP

    更新日期:2021-01-07 00:00:00

  • Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance.

    abstract::The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance between the activity of the donor immune system against malignant and nonmalignant cells of the recipient. Abrogation of alloreactivity will lead to disease relapse, whereas untamed allo-immune responses will lead to l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000951

    authors: Voermans C,Hazenberg MD

    更新日期:2020-07-23 00:00:00

  • Ex vivo incubation with growth factors enhances the engraftment of fetal hematopoietic cells transplanted in sheep fetuses.

    abstract::Hematopoietic stem cells (HSC) transplanted in utero are in competition with endogenous HSC; thus, ultimately the graft constitutes a relatively small fraction of total HSC pool. To enhance the engraftment of donor cells in sheep fetuses, we preincubated these cells, ex vivo, for 16 hours at 37 degrees C with the cond...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zanjani ED,Ascensao JL,Harrison MR,Tavassoli M

    更新日期:1992-06-01 00:00:00

  • Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells.

    abstract::Type I interferons (IFNs-alpha and IFN-beta) bind to a common receptor to exert strong antiproliferative activity on a broad range of cell types, including interleukin-6 (IL-6)-dependent myeloma cells. In this study, we investigated the effect of IFN-beta pretreatment on IL-6-stimulated mitogenic signaling in the huma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berger LC,Hawley RG

    更新日期:1997-01-01 00:00:00

  • Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

    abstract::Children with Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) have a poorer prognosis than do most pediatric patients with ALL. Because of this poor prognosis and the presence of the Ph chromosome, we have asked whether or not Ph + ALL involves a multipotential stem cell. We cultured hematopoietic pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tachibana N,Raimondi SC,Lauer SJ,Sartain P,Dow LW

    更新日期:1987-11-01 00:00:00

  • How I treat acute lymphoblastic leukemia in older adolescents and young adults.

    abstract::At the intersection between children and older adults, the care of adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) poses unique challenges and issues beyond those faced by other age groups. Although the survival of AYA patients is inferior to younger children, growing evidence suggest...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-11-551481

    authors: Curran E,Stock W

    更新日期:2015-06-11 00:00:00

  • High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.

    abstract::Purified T lymphocytes (E rosetting cells) isolated from the involved lymphoid organs (lymph nodes and spleen) of five patients with Hodgkin's disease (HD) were cloned under culture conditions (phytohemagglutinin plus interleukin-2) that allow clonal expansion of most T lymphocytes. A total number of 104 CD4+ T cell c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maggi E,Parronchi P,Macchia D,Bellesi G,Romagnani S

    更新日期:1988-05-01 00:00:00

  • Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.

    abstract::Factor V Leiden (factor V Arg506Gln), the genetic defect underlying resistance to activated protein C, is the most common risk factor for venous thrombosis. The relationship between this genetic abnormality and arterial disease is still unresolved. To assess whether factor V Leiden increases the risk of myocardial inf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosendaal FR,Siscovick DS,Schwartz SM,Beverly RK,Psaty BM,Longstreth WT Jr,Raghunathan TE,Koepsell TD,Reitsma PH

    更新日期:1997-04-15 00:00:00

  • Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

    abstract::Treatment outcomes for older patients with acute myeloid leukemia (AML) have remained dismal. This randomized, phase 2 trial in AML patients not considered suitable for intensive induction therapy compared low-dose cytarabine (LDAC) with or without volasertib, a highly potent and selective inhibitor of polo-like kinas...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-03-560557

    authors: Döhner H,Lübbert M,Fiedler W,Fouillard L,Haaland A,Brandwein JM,Lepretre S,Reman O,Turlure P,Ottmann OG,Müller-Tidow C,Krämer A,Raffoux E,Döhner K,Schlenk RF,Voss F,Taube T,Fritsch H,Maertens J

    更新日期:2014-08-28 00:00:00

  • Basophil tryptase mMCP-11 plays a crucial role in IgE-mediated, delayed-onset allergic inflammation in mice.

    abstract::Recent studies have identified nonredundant roles for basophils in immune responses including allergy and protective immunity. It is well known that activated basophils release granule contents such as histamine and proteases as do mast cells. However, the functional significance of basophil-derived proteases remains ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-729392

    authors: Iki M,Tanaka K,Deki H,Fujimaki M,Sato S,Yoshikawa S,Yamanishi Y,Karasuyama H

    更新日期:2016-12-22 00:00:00

  • A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

    abstract::An unmet need in cell engineering is the availability of a single transgene encoded, functionally inert, human polypeptide that can serve multiple purposes, including ex vivo cell selection, in vivo cell tracking, and as a target for in vivo cell ablation. Here we describe a truncated human EGFR polypeptide (huEGFRt) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337360

    authors: Wang X,Chang WC,Wong CW,Colcher D,Sherman M,Ostberg JR,Forman SJ,Riddell SR,Jensen MC

    更新日期:2011-08-04 00:00:00

  • Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice.

    abstract::Deep venous thrombosis (DVT) remains a common and serious cardiovascular problem with both fatal and long-term consequences. The consequences of DVT include the development of postthrombotic syndrome in 25% to 60% of DVT patients. Despite the clinical importance of venous thrombus resolution, the cellular and molecula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-727180

    authors: Mukhopadhyay S,Antalis TM,Nguyen KP,Hoofnagle MH,Sarkar R

    更新日期:2017-06-15 00:00:00

  • Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.

    abstract::A total of 124 patients who had survived at least 2 years after allogeneic bone marrow transplantation (BMT) were studied. Serum was collected at least once yearly. IgG antibodies were determined by enzyme-linked immunosorbent assay for measles and mumps. Rubella antibodies were analyzed by radial hemolysis. Antibody ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ljungman P,Lewensohn-Fuchs I,Hammarström V,Aschan J,Brandt L,Bolme P,Lönnqvist B,Johansson N,Ringdén O,Gahrton G

    更新日期:1994-07-15 00:00:00

  • Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction.

    abstract::A significant proportion of hemophilia A patients receiving transfusions of factor VIII (FVIII) develop a specific antibody response towards FVIII. These antibodies are usually detected by assays in which they inhibit the function of the molecule, such as the Bethesda clotting test. We have prepared anti-FVIII antibod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gilles JG,Arnout J,Vermylen J,Saint-Remy JM

    更新日期:1993-10-15 00:00:00

  • Donor origin of multipotent adult progenitor cells in radiation chimeras.

    abstract::Multipotent adult progenitor cells (MAPCs) are bone marrow-derived stem cells that have extensive in vitro expansion capacity and can differentiate in vivo and in vitro into tissue cells of all 3 germinal layers: ectoderm, mesoderm, and endoderm. The origin of MAPCs within bone marrow is unknown. MAPCs are believed to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4603

    authors: Reyes M,Li S,Foraker J,Kimura E,Chamberlain JS

    更新日期:2005-11-15 00:00:00

  • ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.

    abstract::A prominent feature of sickle cell anemia is the presence of dehydrated red blood cells (RBCs) in circulation. Loss of potassium (K(+)), chloride (Cl(-)), and water from RBCs is thought to contribute to the production of these dehydrated cells. One main route of K(+) loss in the RBC is the Gardos channel, a calcium (C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1433

    authors: Stocker JW,De Franceschi L,McNaughton-Smith GA,Corrocher R,Beuzard Y,Brugnara C

    更新日期:2003-03-15 00:00:00